clinical trial · NCT07229716
Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects
Guangdong Hengrui Pharmaceutical Co., Ltd·phase1·recruiting·n = 20
Pulmonary FibrosisHRS-9813 CapsuleNintedanib Soft CapsulesPirfenidone Tablets
brief summary
This study aims to evaluate the interaction of oral HRS-9813 capsules with pirfenidone and nintedanib on the pharmacokinetics of healthy subjects.
started
Apr 4, 2026
primary completion
May 1, 2026
completion
May 1, 2026
last updated
Apr 27, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol